Figure 3.

Disease-free survival for patients with high TS activity and low TS activity. The 5-year disease-free survival rates for high and low TS activity were 34% and 73%, respectively. The difference in survival was statistically significant. (P < 0.05)

Ishikawa et al. BMC Cancer 2008 8:188   doi:10.1186/1471-2407-8-188
Download authors' original image